ZMapp antibody delivered by viral vector protects against Ebola infection
by Press Release from Outbreak News Today on (#3HSAH)
A new study comparing the effectiveness of individual ZMapp antibodies versus a cocktail of antibodies, administered to mice using recombinant adeno-associated virus (rAAV) delivery vectors, showed the ability to achieve 100% protection against infection by Ebola virus. The study, which reported the best results using a single rAAV-delivered antibody, is published in Human Gene Therapy, a ["]
The post ZMapp antibody delivered by viral vector protects against Ebola infection appeared first on Outbreak News Today.